Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injections in Knee Osteoarthritis: Single vs Triple Application
NCT02370420Phase 3Completed
- Sponsor
- Universidad Autónoma de Nuevo León
- Start
- Mar 2015
- Primary completion
- Jul 2016
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Universidad Autónoma de Nuevo León. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 24 weeks. Started Mar 2015; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02370420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370420.